21st April 2026
Forterra plc
("Forterra" or the "Company")
Transaction in Own Shares
Forterra plc ("Forterra" or the "Company") announces that it has purchased the following number of its ordinary shares of 1.0 pence each through Investec Bank plc in the period from 13th April 2026 to 17th April 2026.
|
Date |
Venue |
Volume-weighted average price (p) |
Aggregated volume |
Lowest price per share (p) |
Highest price per share (p) |
|
13 April 2026 |
XLON |
163.3363 |
66,495 |
162.2000 |
164.8000 |
|
14 April 2026 |
XLON |
167.5059 |
64,802 |
163.8000 |
168.8000 |
|
15 April 2026 |
XLON |
166.4345 |
56,539 |
164.6000 |
168.4000 |
|
16 April 2026 |
XLON |
165.4106 |
43,804 |
164.6000 |
167.0000 |
|
17 April 2026 |
XLON |
167.9565 |
71,486 |
164.0000 |
170.6000 |
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Market Abuse Regulation (EU) No 596/2014 (as it forms part of the law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as implemented, retained, amended, extended, re-enacted or otherwise given effect in the United Kingdom from 1 January 2021 and as amended or supplemented in the United Kingdom thereafter) a full breakdown of the individual trades made by Investec Bank plc on behalf of the Company as part of the Programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/3388B_1-2026-4-21.pdf
END
Enquires
Forterra plc: +44 (0) 1604 707 600
Ben Guyatt (CFO)
Frances Tock (Company Secretary)
Further information relating to the Company and its group can be found at www.forterraplc.co.uk
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.